DE69904297T2 - Neue verwendung von ropivacain zur schmerzbehandlung - Google Patents

Neue verwendung von ropivacain zur schmerzbehandlung

Info

Publication number
DE69904297T2
DE69904297T2 DE69904297T DE69904297T DE69904297T2 DE 69904297 T2 DE69904297 T2 DE 69904297T2 DE 69904297 T DE69904297 T DE 69904297T DE 69904297 T DE69904297 T DE 69904297T DE 69904297 T2 DE69904297 T2 DE 69904297T2
Authority
DE
Germany
Prior art keywords
ropivacain
new use
pain treatment
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69904297T
Other languages
English (en)
Other versions
DE69904297D1 (de
Inventor
Goeran Isacsson
Dag Selander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69904297D1 publication Critical patent/DE69904297D1/de
Publication of DE69904297T2 publication Critical patent/DE69904297T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
DE69904297T 1998-01-21 1999-01-11 Neue verwendung von ropivacain zur schmerzbehandlung Expired - Lifetime DE69904297T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9800139A SE9800139D0 (sv) 1998-01-21 1998-01-21 New use
PCT/SE1999/000012 WO1999037301A1 (en) 1998-01-21 1999-01-11 New use for pain management

Publications (2)

Publication Number Publication Date
DE69904297D1 DE69904297D1 (de) 2003-01-16
DE69904297T2 true DE69904297T2 (de) 2003-08-21

Family

ID=20409917

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69904297T Expired - Lifetime DE69904297T2 (de) 1998-01-21 1999-01-11 Neue verwendung von ropivacain zur schmerzbehandlung

Country Status (11)

Country Link
US (2) US6395291B1 (de)
EP (1) EP1054671B1 (de)
JP (1) JP4456754B2 (de)
AT (1) ATE228840T1 (de)
AU (1) AU2444399A (de)
DE (1) DE69904297T2 (de)
DK (1) DK1054671T3 (de)
ES (1) ES2189386T3 (de)
PT (1) PT1054671E (de)
SE (1) SE9800139D0 (de)
WO (1) WO1999037301A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200611217A (en) * 2005-12-06 2006-04-01 Shin Hwa Biotech Co Ltd Human model for indexing nerve paths (locus) having corresponding relations and method for indexing
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
US20160030409A1 (en) * 2014-07-30 2016-02-04 Grigory Karmy Method for relieving chronic pain
US10751249B2 (en) * 2017-11-26 2020-08-25 Johnson Athletic Advantage LLC Trigger point dry needling in motion and method of use
BE1026845B1 (nl) 2018-12-07 2020-07-08 Fagron Compounding Services Nv Samenstelling voor gebruik in lokale infiltratie analgesie (LIA)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE451840B (sv) 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning
SE9401174D0 (sv) 1994-04-07 1994-04-07 Astra Ab New combination
US5962532A (en) 1997-03-13 1999-10-05 Campbell; James N. Therapeutic method with capsaicin and capsaicin analogues

Also Published As

Publication number Publication date
JP2002501021A (ja) 2002-01-15
AU2444399A (en) 1999-08-09
WO1999037301A1 (en) 1999-07-29
EP1054671A1 (de) 2000-11-29
ATE228840T1 (de) 2002-12-15
SE9800139D0 (sv) 1998-01-21
US6395291B1 (en) 2002-05-28
JP4456754B2 (ja) 2010-04-28
US6620423B2 (en) 2003-09-16
EP1054671B1 (de) 2002-12-04
ES2189386T3 (es) 2003-07-01
DE69904297D1 (de) 2003-01-16
US20020156101A1 (en) 2002-10-24
DK1054671T3 (da) 2003-02-24
PT1054671E (pt) 2003-03-31

Similar Documents

Publication Publication Date Title
DE60141230D1 (de) Verwendung von Botulinum Toxin zur Behandlung von neuralgischen Schmerzen
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69435321D1 (de) Verwendung von Botulinum Toxin zur Behandlung des myofascialen Schmerzsyndroms
DE69825286D1 (de) Verwendung von cholinesterasehemmern zur behandlung von aufmerksamkeitsmangel-störungen
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
DE69904297T2 (de) Neue verwendung von ropivacain zur schmerzbehandlung
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE264101T1 (de) Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
ATE238795T1 (de) Verwendung von aminothiazolen zur wund- und hautbehandlung
ATE337004T1 (de) Verwendung von mangafodipir zur behandlung der hepatozellularen insuffizienz
ATE369143T1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE275949T1 (de) Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria
DE69806062D1 (de) Kombinationstherapie zur behandlung von aids
DE59904564D1 (de) Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
ATE297727T1 (de) Verwendung von anethol-dithiolethion zur vorbeugung und behandlung der sehnentoxizität
ATE288263T1 (de) Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
DE50000676D1 (de) Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation zur behandlung von pankreatitis
DE69907685D1 (de) Verwendung von derivaten von tetrahydropyridinen oder (4-hydroxypiperidin)-butylazolen zur herstellung von präparaten zur schmerzbehandlung
DE60129599D1 (de) Faktor xiii in kombination mit faktor ix zur behandlung von hämophilie b

Legal Events

Date Code Title Description
8364 No opposition during term of opposition